The 36-month beta value for SVRA is at 0.31. Analysts have varying views on the stock, with 4 analysts rating it as a “buy,” 3 rating it as “overweight,” 1 as “hold,” and 0 as “sell.”
The public float for SVRA is 78.22M, and currently, shorts hold a 23.34% of that float. The average trading volume for SVRA on May 29, 2025 was 1.48M shares.
SVRA) stock’s latest price update
Savara Inc (NASDAQ: SVRA)’s stock price has plunge by 2.44relation to previous closing price of 2.13. Nevertheless, the company has seen a -24.84% plunge in its stock price over the last five trading sessions. accessnewswire.com reported 2025-05-28 that NEW YORK, NY / ACCESS Newswire / May 28, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of Savara Inc. (“Savara Inc.”) (NASDAQ:SVRA) concerning possible violations of federal securities laws. On May 27, 2025, the company announced that the FDA issued a Refusal to File letter for its Biologics License Application for Molbreevi, its lead drug candidate for autoimmune PAP.
SVRA’s Market Performance
Savara Inc (SVRA) has seen a -24.84% fall in stock performance for the week, with a -32.91% decline in the past month and a -11.09% plunge in the past quarter. The volatility ratio for the week is 20.93%, and the volatility levels for the past 30 days are at 9.90% for SVRA. The simple moving average for the past 20 days is -25.16% for SVRA’s stock, with a -33.93% simple moving average for the past 200 days.
Analysts’ Opinion of SVRA
Wells Fargo, on the other hand, stated in their research note that they expect to see SVRA reach a price target of $8. The rating they have provided for SVRA stocks is “Overweight” according to the report published on December 20th, 2024.
Evercore ISI gave a rating of “In-line” to SVRA, setting the target price at $5 in the report published on November 13th of the previous year.
SVRA Trading at -25.32% from the 50-Day Moving Average
After a stumble in the market that brought SVRA to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -57.20% of loss for the given period.
Volatility was left at 9.90%, however, over the last 30 days, the volatility rate increased by 20.93%, as shares sank -32.66% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -23.04% lower at present.
During the last 5 trading sessions, SVRA fell by -25.95%, which changed the moving average for the period of 200-days by -45.85% in comparison to the 20-day moving average, which settled at $2.92. In addition, Savara Inc saw -28.76% in overturn over a single year, with a tendency to cut further losses.
Insider Trading
Reports are indicating that there were more than several insider trading activities at SVRA starting from RAMSAY DAVID A, who purchase 150,000 shares at the price of $2.77 back on Mar 31 ’25. After this action, RAMSAY DAVID A now owns 2,513,642 shares of Savara Inc, valued at $416,250 using the latest closing price.
Lowrance David L, the Chief Financial Officer of Savara Inc, sale 25,000 shares at $3.33 during a trade that took place back on Dec 16 ’24, which means that Lowrance David L is holding 381,005 shares at $83,278 based on the most recent closing price.
Stock Fundamentals for SVRA
Current profitability levels for the company are sitting at:
- -401.31 for the present operating margin
- 0.25 for the gross margin
The net margin for Savara Inc stands at -375.64. The total capital return value is set at -0.62. Equity return is now at value -75.77, with -58.79 for asset returns.
Based on Savara Inc (SVRA), the company’s capital structure generated 0.17 points at debt to capital in total, while cash flow to debt ratio is standing at -3.24.
Currently, EBITDA for the company is -103.07 million with net debt to EBITDA at -0.09. When we switch over and look at the enterprise to sales, we see a ratio of 1412.35. The liquidity ratio also appears to be rather interesting for investors as it stands at 14.91.
Conclusion
In conclusion, Savara Inc (SVRA) has had a bad performance lately. Opinion on the stock among analysts is bullish, with some giving it a “buy” rating and others a “hold”. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
